SpecialtiesQuestion

For pediatric severe aplastic anemia, is an alemtuzumab (campath) based conditioning regimen preferred over ATG?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What is your preferred treatment for refractory warm autoimmune hemolytic anemia with autoimmune neutropenia?

How would you manage HHT with ongoing epistaxis despite IV bevacizumab, with a history of superficial thrombosis?

For transplant-ineligible aplastic anemia planned for immunosuppression, how do you approach duration and tapering of cyclosporine and eltrombopag?

Do you see a role for omidubicel upfront in severe aplastic anemia for patients without a matched donor?

Following long-term efficacy and safety data from the beti-cel trials, how do you approach gene therapy for eligible patients with transfusion-dependent β-thalassemia?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.